Literature DB >> 12127043

Steroid sulfatase activity and expression in mammary myoepithelial cells.

Joanne K Tobacman1, Marilyn Hinkhouse, Zhila Khalkhali-Ellis.   

Abstract

PURPOSE: This investigation examined mRNA expression and enzymatic activity of steroid sulfatase (STS) in human mammary myoepithelial cells (MMECs) and MCF-7 cells and assessed the effects of 17-beta estradiol on the activity of STS.
METHODS: The mRNA level of STS in MMECs was determined by RT-PCR analysis using specific primers for STS. STS enzymatic activity prior to and after treatment with 17-beta estradiol was determined by measuring 3H-metabolites formed after exposure to [3H]estrone 3-sulfate (E1S) and [3H]dehydroepiandrosterone-sulfate (DHEA-S).
RESULTS: Our data demonstrate the presence of STS in the MMECs. Based on RT-PCR analysis, MMECs had slightly lower levels of STS compared to MCF-7 cells. However, sulfatase activity was about 120 times greater in the MMECs than the MCF-7 cells (E1S V(max)=2640nmol/(mg DNAh) compared to 20.9nmol/(mg DNAh)). Exposure to 17-beta estradiol was associated with 70% reduction in E1S sulfatase activity in the MCF-7 cells and 9% increase in the MMECs after 6 days. DISCUSSION: Our studies indicate for the first time the presence of STS in MMECs. This is suggestive of a previously undetermined role for MMECs in converting precursor hormones into active steroid hormones within mammary tissue. In addition, differential response of the MMECs and the MCF-7 cells to estrogen demonstrates differences in hormone metabolism between these two cell types, perhaps related to the absence of estrogen receptors in the MMECs and their presence in the MCF-7 cells. The MMECs may have an important role in hormonal regulation within mammary tissue.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12127043     DOI: 10.1016/s0960-0760(02)00048-1

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  7 in total

1.  The Role of Androgens in Normal and Malignant Breast Tissue.

Authors:  Katharina Tiefenbacher; Günter Daxenbichler
Journal:  Breast Care (Basel)       Date:  2008-10-16       Impact factor: 2.860

2.  Metastatic progression of pancreatic cancer: changes in antioxidant enzymes and cell growth.

Authors:  Anne Lewis; Juan Du; Jingru Liu; Justine M Ritchie; Larry W Oberley; Joseph J Cullen
Journal:  Clin Exp Metastasis       Date:  2006-02-11       Impact factor: 5.150

Review 3.  Do myoepithelial cells hold the key for breast tumor progression?

Authors:  Kornelia Polyak; Min Hu
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-07       Impact factor: 2.698

4.  Exposure to common food additive carrageenan alone leads to fasting hyperglycemia and in combination with high fat diet exacerbates glucose intolerance and hyperlipidemia without effect on weight.

Authors:  Sumit Bhattacharyya; Leo Feferman; Terry Unterman; Joanne K Tobacman
Journal:  J Diabetes Res       Date:  2015-03-25       Impact factor: 4.011

5.  Does rapid metabolism ensure negligible risk from bisphenol A?

Authors:  Gary Ginsberg; Deborah C Rice
Journal:  Environ Health Perspect       Date:  2009-07-14       Impact factor: 9.031

6.  Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion.

Authors:  Yan-gao Man; Lisa Tai; Ross Barner; Russell Vang; Jeffrey S Saenger; Kris M Shekitka; Gary L Bratthauer; Darren T Wheeler; Chang Y Liang; Tuyethoa N Vinh; Brian L Strauss
Journal:  Breast Cancer Res       Date:  2003-10-03       Impact factor: 6.466

7.  Physiologically Based Pharmacokinetic (PBPK) Modeling of the Bisphenols BPA, BPS, BPF, and BPAF with New Experimental Metabolic Parameters: Comparing the Pharmacokinetic Behavior of BPA with Its Substitutes.

Authors:  Cecile Karrer; Thomas Roiss; Natalie von Goetz; Darja Gramec Skledar; Lucija Peterlin Mašič; Konrad Hungerbühler
Journal:  Environ Health Perspect       Date:  2018-07-10       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.